Pigmented Lesion Treatment Market Report 2025

The pigmented lesion treatment market size has grown strongly in recent years. It will grow from $3.31 billion in 2024 to $3.57 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to the rising prevalence of hyperpigmentation disorders, growing awareness of aesthetic dermatology, increasing disposable incomes, higher demand for non-invasive cosmetic procedures, and an increased focus on skin health and appearance.

The pigmented lesion treatment market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be attributed to rising consumer spending on aesthetic procedures, increasing adoption of home-use pigmentation devices, growing demand for personalized skin treatments, the rising influence of beauty and wellness influencers, greater acceptance of male aesthetic treatments, and the expanding availability of combination therapies. Key trends expected during the forecast period include the integration of teledermatology services, innovations in non-invasive treatment modalities, development of personalized treatment protocols, adoption of multi-modal therapies, and incorporation of electronic health records.

The rising prevalence of skin disorders is expected to drive the growth of the pigmented lesion treatment market in the coming years. Skin disorders encompass a wide range of conditions affecting the structure, function, or appearance of the skin, often causing inflammation, irritation, or abnormal growths. These include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. The increasing prevalence of skin disorders is largely attributed to environmental pollution, as pollutants can compromise the skin barrier and trigger inflammatory or allergic responses. Pigmented lesion treatments target abnormal skin pigmentation, making them effective for conditions such as age spots, melasma, and freckles. By improving skin appearance through precise technologies, these treatments enhance dermatological care and patient confidence. For example, in 2023, Cancer Australia, a government agency, reported approximately 8,257 new cases of melanoma of the skin, accounting for 2.6% of all cancer-related deaths. Consequently, the growing prevalence of skin disorders is fueling the pigmented lesion treatment market.

Leading companies in the pigmented lesion treatment market are developing advanced products, such as dual-wavelength fractional laser systems, to improve treatment precision and effectiveness for various pigmentation issues. Dual-wavelength fractional laser systems are sophisticated dermatological devices that combine two laser wavelengths to simultaneously target superficial and deep skin layers for more effective treatment of pigmented lesions and skin rejuvenation. For instance, in April 2025, Bausch Health Companies Inc., a Canada-based pharmaceutical company, and Solta Medical Corporation, a US-based aesthetics division of Bausch Health, launched Fraxel FTX, an advanced laser resurfacing system. This device features dual-wavelength fractional lasers with 1550 nm erbium-glass and 1927 nm thulium designed to target both deep and superficial skin layers. It also includes a redesigned handpiece that is 20% lighter and integrated cooling technology to enhance patient comfort. Additionally, it incorporates intelligent optical tracking with Accutrac for precise and consistent treatment delivery and a modern color touchscreen interface for customizable treatment options.

In April 2024, Hahn & Company LLC, a South Korea-based private equity firm, acquired Cynosure LLC for an undisclosed amount. Through this acquisition, Hahn & Company aims to merge Cynosure and Lutronic into Cynosure Lutronic Inc., combining technological innovations, expanding market reach, enhancing R\&D, and offering comprehensive solutions. Cynosure LLC is a US-based medical aesthetics technology company specializing in laser systems for pigmented lesion treatment.

Major players in the pigmented lesion treatment market are EL.EN S.p.A., Candela Medical Corporation, Alma Lasers Ltd., Cutera Inc., Lutronic Corporation, Fotona d.o.o., Sciton Inc., Solta Medical Inc., Inmode Ltd., Strata Skin Sciences Inc., Lumenis Ltd., Syneron Medical Ltd., Quanta System S.P.A, Sharplight Technologies Ltd., Beijing Sincoheren Science and Technology Development Co. Ltd., Venus Concept Inc., Lynton Lasers Ltd., Eufoton S.R.L., Asclepion Laser Technologies Gmbh, DEKA M.E.L.A. Srl.

North America was the largest region in the pigmented lesion treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pigmented lesion treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pigmented lesion treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Pigmented lesion treatment refers to medical or aesthetic procedures designed to reduce or remove areas of skin discoloration caused by excess melanin, which can result from factors such as sun exposure, hormonal changes, or aging. These treatments aim to restore an even skin tone, enhance skin appearance, and address pigmentation-related cosmetic or dermatological concerns.

The primary types of pigmented lesion treatments include laser therapy, topical creams, chemical peels, microdermabrasion, and others. Laser therapy is a medical treatment that uses focused light energy to target and treat specific tissues for therapeutic or cosmetic purposes. The associated product types include lasers and energy-based devices, radiofrequency (RF) devices, micro-focused ultrasound, and intense pulsed light devices suitable for different age groups, including children, adults, and older adults. These treatments are applied to conditions such as melasma, freckles, age spots, nevi, and others, serving end users including dermatology clinics, beauty clinics, and related facilities.

The pigmented lesion treatment market research report is one of a series of new reports that provides pigmented lesion treatment market statistics, including pigmented lesion treatment industry global market size, regional shares, competitors with a pigmented lesion treatment market share, detailed pigmented lesion treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmented lesion treatment industry. This pigmented lesion treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pigmented lesion treatment market consists of revenues earned by entities by providing services such as cryotherapy services, phototherapy sessions, pigmentation mapping and monitoring, and customized pigmentation treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmented lesion treatment market also includes sales of cryotherapy equipment, dermabrasion tools, skin-lightening serums, and phototherapy units. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.